ResearcherYanbian UniversityNo recent work listed
Aihua Jin
Matched on OpenAlex author ID A5101049255. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2014: 1 paper · 2015: none · 2016: none · 2017: 3 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 5
- miR-590-5p/Tiam1-mediated glucose metabolism promotes malignant evolution of pancreatic cancer by regulating SLC2A3 stability. First author DOI 10.1186/s12935-023-03159-3↗
- Mortalin expression in pancreatic cancer and its clinical and prognostic significance. Last author DOI 10.1016/j.humpath.2017.03.015↗
- Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma. First author DOI 10.3892/ol.2017.5821↗
- DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/or.2016.5302↗
- Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.yexmp.2013.11.003↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhenhua Lin · 3 shared papers, 2017–2023 · strength 0.36
- Paper miR-590-5p/Tiam1-mediated glucose metabolism promotes malignant evolution of pancreatic cancer by regulating SLC2A3 sta… DOI 10.1186/s12935-023-03159-3↗
- Paper Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma. DOI 10.3892/ol.2017.5821↗
- Paper DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma. DOI 10.3892/or.2016.5302↗
- Ying Liu · 1 shared paper, 2023 · strength 0.20
- Xuelian Cui · 2 shared papers, 2017 · strength 0.15
- Jie Lena Sun · 2 shared papers, 2017 · strength 0.15
- Zhenhua Lin · 2 shared papers, 2014–2017 · strength 0.12
- Meiying Ji · 1 shared paper, 2017 · strength 0.08
- Yang Yang · 1 shared paper, 2017 · strength 0.08
- Liyan Chen · 1 shared paper, 2017 · strength 0.08
- Junjie Piao · 1 shared paper, 2017 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.